Cochrane Abstracts
Anti‐vascular endothelial growth factor for neovascular glaucoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anti‐vascular Endothelial Growth Factor for Neovascular Glaucoma." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438848/0/Anti‐vascular_endothelial_growth_factor_for_neovascular_glaucoma.
Anti‐vascular endothelial growth factor for neovascular glaucoma. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438848/0/Anti‐vascular_endothelial_growth_factor_for_neovascular_glaucoma. Accessed January 14, 2025.
Anti‐vascular endothelial growth factor for neovascular glaucoma. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438848/0/Anti‐vascular_endothelial_growth_factor_for_neovascular_glaucoma
Anti‐vascular Endothelial Growth Factor for Neovascular Glaucoma [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2025 January 14]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438848/0/Anti‐vascular_endothelial_growth_factor_for_neovascular_glaucoma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anti‐vascular endothelial growth factor for neovascular glaucoma
ID - 438848
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438848/0/Anti‐vascular_endothelial_growth_factor_for_neovascular_glaucoma
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
